• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Intestinal Microbiome, Plasma Metabolome, and Liver Transcriptome: A Conspiracy Driving Hepatic Steatosis.

作者信息

Mehal Wajahat Z, Loomba Rohit

机构信息

West Haven Veterans Medical Center, West Haven, CT.

Section of Digestive Diseases, Yale University, New Haven, CT.

出版信息

Hepatology. 2019 Aug;70(2):741-744. doi: 10.1002/hep.30577. Epub 2019 Apr 11.

DOI:10.1002/hep.30577
PMID:30779368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6984973/
Abstract
摘要

相似文献

1
The Intestinal Microbiome, Plasma Metabolome, and Liver Transcriptome: A Conspiracy Driving Hepatic Steatosis.肠道微生物组、血浆代谢组和肝脏转录组：驱动肝脂肪变性的一个“阴谋”
Hepatology. 2019 Aug;70(2):741-744. doi: 10.1002/hep.30577. Epub 2019 Apr 11.
2
Mechanisms of hepatic steatosis in chickens: integrated analysis of the host genome, molecular phenomics and gut microbiome.鸡脂肪肝形成的机制：宿主基因组、分子表型和肠道微生物组的综合分析。
Gigascience. 2024 Jan 2;13. doi: 10.1093/gigascience/giae023.
3
Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancer.肥胖诱导的肠道癌小鼠模型中结肠转录组、代谢组和微生物组之间的相互作用。
Physiol Genomics. 2016 Aug 1;48(8):545-53. doi: 10.1152/physiolgenomics.00034.2016. Epub 2016 Jun 17.
4
Maternal obesity characterized by gestational diabetes increases the susceptibility of rat offspring to hepatic steatosis via a disrupted liver metabolome.以妊娠期糖尿病为特征的母体肥胖通过肝脏代谢组紊乱增加了大鼠后代患肝脂肪变性的易感性。
J Physiol. 2015 Jul 15;593(14):3181-97. doi: 10.1113/JP270429. Epub 2015 Jun 12.
5
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝炎发生过程中肠道微生物组和代谢组的动态变化。
World J Gastroenterol. 2018 Jun 21;24(23):2468-2481. doi: 10.3748/wjg.v24.i23.2468.
6
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.瑞士乳杆菌 R0052 通过调节半乳糖胺处理大鼠的肠道微生物组和代谢组缓解肝损伤。
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9673-9686. doi: 10.1007/s00253-019-10211-8. Epub 2019 Nov 12.
7
Prosteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement System.独特的脂肪肝模型中的亲脂性和保护性成分：肠道微生物群和受抑制的补体系统。
Sci Rep. 2016 Aug 23;6:31763. doi: 10.1038/srep31763.
8
Metabolic profiling of ob/ob mouse fatty liver using HR-MAS H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway.使用高分辨魔角旋转氢核磁共振（HR-MAS H-NMR）结合基因表达分析对ob/ob小鼠脂肪肝进行代谢谱分析，揭示了甜菜碱代谢和转硫途径的改变。
Anal Bioanal Chem. 2017 Feb;409(6):1591-1606. doi: 10.1007/s00216-016-0100-1. Epub 2016 Nov 28.
9
[Not Available].[无可用内容]
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(4):258a. doi: 10.2177/jsci.40.258a.
10
Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.肝脂肪变性患者肝葡萄糖-6-磷酸酶-α的下调。
Obesity (Silver Spring). 2011 Dec;19(12):2322-6. doi: 10.1038/oby.2011.118. Epub 2011 May 19.

引用本文的文献

1
Metabolic dysfunction-associated steatotic liver disease in people with HIV.HIV感染者中与代谢功能障碍相关的脂肪性肝病
Curr Opin HIV AIDS. 2025 Jul 1;20(4):350-358. doi: 10.1097/COH.0000000000000952. Epub 2025 May 21.
2
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝炎的当前治疗现状
Int J Mol Sci. 2025 Feb 19;26(4):1778. doi: 10.3390/ijms26041778.
3
Vitamin E for people with non-alcoholic fatty liver disease.维生素 E 治疗非酒精性脂肪性肝病。
Cochrane Database Syst Rev. 2024 Oct 16;10(10):CD015033. doi: 10.1002/14651858.CD015033.pub2.
4
NASH and the Gut Microbiome: Implications for New Therapies.非酒精性脂肪性肝炎与肠道微生物群：对新疗法的启示
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):97-100. doi: 10.1002/cld.1170. eCollection 2022 Mar.
5
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model.熊去氧胆酸治疗可恢复非酒精性脂肪性肝炎小鼠模型的肠道微生物群并减轻肝脏炎症
Front Pharmacol. 2021 Dec 6;12:788558. doi: 10.3389/fphar.2021.788558. eCollection 2021.

本文引用的文献

1
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.微生物组 101：临床医生的肠道微生物组数据研究、分析和解读。
Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230. doi: 10.1016/j.cgh.2018.09.017. Epub 2018 Sep 18.
2
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function.肠道微生物组在非酒精性脂肪性肝病中的新作用：从组成到功能。
Clin Gastroenterol Hepatol. 2019 Jan;17(2):296-306. doi: 10.1016/j.cgh.2018.08.065. Epub 2018 Sep 7.
3
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.非糖尿病肥胖女性肝脂肪变性的分子表型和宏基因组学。
Nat Med. 2018 Jul;24(7):1070-1080. doi: 10.1038/s41591-018-0061-3. Epub 2018 Jun 25.
4
The gut-liver axis and the intersection with the microbiome.肠-肝轴与微生物组的交汇。
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):397-411. doi: 10.1038/s41575-018-0011-z.
5
Current understanding of the human microbiome.人类微生物组的现有认识。
Nat Med. 2018 Apr 10;24(4):392-400. doi: 10.1038/nm.4517.
6
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.肠道微生物衍生代谢物与非酒精性脂肪性肝病肝脂肪变性和纤维化的共享基因效应之间的关系。
Hepatology. 2018 Sep;68(3):918-932. doi: 10.1002/hep.29892. Epub 2018 May 20.
7
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的肠道微生物组。
Clin Liver Dis. 2018 Feb;22(1):121-132. doi: 10.1016/j.cld.2017.08.009.
8
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention.肥胖及减肥干预后肠道微生物组和血清代谢组的改变。
Nat Med. 2017 Jul;23(7):859-868. doi: 10.1038/nm.4358. Epub 2017 Jun 19.
9
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.基于肠道微生物群的宏基因组特征用于非侵入性检测人类非酒精性脂肪性肝病中的晚期纤维化
Cell Metab. 2017 May 2;25(5):1054-1062.e5. doi: 10.1016/j.cmet.2017.04.001.